US tightens oversight of gene-therapy trials.

Reports on the launch of two initiatives by the United States Food & Drug Administration and the National Institutes of Health aimed to protect patients participating in gene-therapy trials. Basis of the programs in light of the death of test patient Jesse Gelsinger in September 1999; Adjustment of government regulations of gene therapy by way of the Gene Therapy Clinical Trial Monitoring Plan; Launch of public meeting among researchers to discuss safety during the Gene Transfer Safety Symposia.